OpenURL Connection Search

Select item for more details and to access through your institution.

Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2015, v. 58, n. 6, p. 242, doi. 10.1002/jlcr.3293
By:
- Kumar, Pardeep;
- Singh, Baljinder;
- Ghai, Anchal;
- Hazari, Puja P.;
- Mittal, B. R.;
- Mishra, Anil K.
Publication type:
Article
Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival.
Published in:
Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-021-03748-0
By:
- Hathi, Deep;
- Chanswangphuwana, Chantiya;
- Cho, Nicholas;
- Fontana, Francesca;
- Maji, Dolonchampa;
- Ritchey, Julie;
- O'Neal, Julie;
- Ghai, Anchal;
- Duncan, Kathleen;
- Akers, Walter J.;
- Fiala, Mark;
- Vij, Ravi;
- DiPersio, John F.;
- Rettig, Michael;
- Shokeen, Monica
Publication type:
Article
Development of New CD38 Targeted Peptides for Cancer Imaging.
Published in:
Molecular Imaging & Biology, 2024, v. 26, n. 4, p. 738, doi. 10.1007/s11307-024-01901-5
By:
- Zheleznyak, Alexander;
- Tang, Rui;
- Duncan, Kathleen;
- Manion, Brad;
- Liang, Kexian;
- Xu, Baogang;
- Vanover, Alexander;
- Ghai, Anchal;
- Prior, Julie;
- Lees, Stephen;
- Achilefu, Samuel;
- Kelly, Kimberly;
- Shokeen, Monica
Publication type:
Article
In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [18F]FDG and [64Cu]Cu-LLP2A PET.
Published in:
EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00840-4
By:
- Ghai, Anchal;
- Fettig, Nikki;
- Fontana, Francesca;
- DiPersio, John;
- Rettig, Mike;
- Neal, Julie O.;
- Achilefu, Samuel;
- Shoghi, Kooresh I.;
- Shokeen, Monica
Publication type:
Article
First-in-Humans Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging.
Published in:
Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 320, doi. 10.2967/jnumed.122.264349
By:
- Laforest, Richard;
- Ghai, Anchal;
- Fraum, Tyler J.;
- Reiko Oyama;
- Frye, Jennifer;
- Kaemmerer, Helen;
- Gaehle, Greg;
- Voller, Tom;
- Mpoy, Cedric;
- Rogers, Buck E.;
- Fiala, Mark;
- Shoghi, Kooresh I.;
- Achilefu, Samuel;
- Rettig, Michael;
- Vij, Ravi;
- DiPersio, John F.;
- Schwarz, Sally;
- Shokeen, Monica;
- Dehdashti, Farrokh
Publication type:
Article
First-in-Human Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.122.264349
By:
- Laforest, Richard;
- Ghai, Anchal;
- Fraum, Tyler J.;
- Oyama, Reiko;
- Frye, Jennifer;
- Kaemmerer, Helen;
- Gaehle, Greg;
- Voller, Tom;
- Mpoy, Cedric;
- Rogers, Buck E.;
- Fiala, Mark;
- Shoghi, Kooresh I.;
- Achilefu, Samuel;
- Rettig, Michael;
- Vij, Ravi;
- DiPersio, John F.;
- Schwarz, Sally;
- Shokeen, Monica;
- Dehdashti, Farrokh
Publication type:
Article
First-in-Human Evaluation of Safety and Dosimetry of 64Cu-LLP2A for PET Imaging.
Published in:
Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.122.264349
By:
- Laforest, Richard;
- Ghai, Anchal;
- Fraum, Tyler J.;
- Oyama, Reiko;
- Frye, Jennifer;
- Kaemmerer, Helen;
- Gaehle, Greg;
- Voller, Tom;
- Mpoy, Cedric;
- Rogers, Buck E.;
- Fiala, Mark;
- Shoghi, Kooresh I.;
- Achilefu, Samuel;
- Rettig, Michael;
- Vij, Ravi;
- DiPersio, John F.;
- Schwarz, Sally;
- Shokeen, Monica;
- Dehdashti, Farrokh
Publication type:
Article
Preclinical Development of CD38-Targeted [89Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.
Published in:
Journal of Nuclear Medicine, 2018, v. 59, n. 2, p. 216, doi. 10.2967/jnumed.117.196063
By:
- Ghai, Anchal;
- Maji, Dolonchampa;
- Cho, Nicholas;
- Chanswangphuwana, Chantiya;
- Rettig, Michael;
- Duanwen Shen;
- DiPersio, John;
- Akers, Walter;
- Dehdashti, Farrokh;
- Achilefu, Samuel;
- Vij, Ravi;
- Shokeen, Monica
Publication type:
Article
Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1302, doi. 10.1007/s00259-020-05097-y
By:
- Ghai, Anchal;
- Zheleznyak, Alexander;
- Mixdorf, Matt;
- O'Neal, Julie;
- Ritchey, Julie;
- Rettig, Michael;
- DiPersio, John;
- Shokeen, Monica;
- Achilefu, Samuel
Publication type:
Article
Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study.
Published in:
American Journal of Gastroenterology (Springer Nature), 2013, v. 108, n. 4, p. 560, doi. 10.1038/ajg.2013.9
By:
- Singh, Virendra;
- Singh, Ajay;
- Singh, Baljinder;
- Vijayvergiya, Rajesh;
- Sharma, Navneet;
- Ghai, Anchal;
- Bhalla, Ashish
Publication type:
Article

Found: 10

Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results.

Ablation of VLA4 in multiple myeloma cells redirects tumor spread and prolongs survival.

Development of New CD38 Targeted Peptides for Cancer Imaging.

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [<sup>18</sup>F]FDG and [<sup>64</sup>Cu]Cu-LLP2A PET.

First-in-Humans Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.

First-in-Human Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.

First-in-Human Evaluation of Safety and Dosimetry of <sup>64</sup>Cu-LLP2A for PET Imaging.

Preclinical Development of CD38-Targeted [<sup>89</sup>Zr]Zr-DFO-Daratumumab for Imaging Multiple Myeloma.

Development of [89Zr]DFO-elotuzumab for immunoPET imaging of CS1 in multiple myeloma.

Midodrine and Clonidine in Patients With Cirrhosis and Refractory or Recurrent Ascites: A Randomized Pilot Study.